|
Investigation summary: scope of issue: the scope of issue is only limited to facslyric 3l10c instrument us, part # 662878, serial # (b)(6).Problem statement: customer reported a complaint regarding carryover between sample tests.Manufacturing defect trend: there are 0 qns (quality notifications) related to the reported issue.Date range from 16jul2020 to date 16jul2021.Complaint trend: there are 4 complaints related to the issue of carry over; date range from 16jul2020 to date 16jul2021.Manufacturing device history record (dhr) review: dhr part #662878, serial # (b)(6), file #: (b)(4), was reviewed.The instrument met all the manufacturing specifications prior to release.Investigation result / analysis: the investigation was performed and based on the review of the complaint trend, defect trend, dhr, risk analysis and servicemax, the root cause of carryover was due to worn fluidics tubing.The customer had initially noticed the erroneous results when comparing the instrument¿s results with another lyric, and reported the carryover.The fse (field service engineer) responding to this complaint confirmed the issue and replaced the sit tubing (pn 652784) and 4 way valve manifold (pn 654891).No parts were requested for evaluation as the replaced parts are not returnable and were discarded.After the repair, the instrument was tested and functioning as expected.Although the unexpected results were from patient samples for clinical use, no patient was treated nor harmed from incorrect results.The results were captured prior to any diagnosis decision and was reported to bd as not expected.Proper daily and monthly cleaning procedures can be found under ¿maintenance¿ in the user guide; bd facslyric¿ clinical system instructions for use, #23-19938-02 rev.1/vers.A, page 165.The safety risk is moderate, s3, and there was no impact to patient health or safety.Service max review: review of related work order #: (b)(4), case # (b)(4) install date: (b)(6) 2019.Defective part number: 654891 - four valve subassy (sheath) service.652784 - liberty peek tbg kit -no flow sensor opt work order notes: o subject / reported: having carryover issues.O problem description: caller is testing sample carryover and this lyric has a lot of carryover compared to their other lyric.O work performed: replaced tubing 4 way valve maiifold and replaced sit tubing.Ran checks for carryover.Passed biut cusomer wants runtime.Retured to check system.Closing call and returning unit to customer for full use.O cause: reduced volume of sheath fluid cleaning sit.O solution: ran checks for carryover.Closing call and returning unit to customer for full use.Returned sample evaluation: a return sample was not requested because the replaced parts are not returnable and were discarded.Risk analysis: risk management file part # 10000063058, rev.03/vers.X, bd facslyric system risk analysis was reviewed.No new hazards have been identified and the current mitigations are sufficient.Hazard(s) identified? yes no o azure id: 89209; o id: libivd-ra-100 3.1.7; o reg status: ivd; ruo; o hazard: incorrect output for samples up to1.5ml or less.O cause: sample carryover error -fluidic.O harmful effects: events appear in wrong tube (false positive result).O risk control: proper sit flushing between samples.Droplet containment to manage back dripping into samples.O req link (azure id): 89923 libivd-fld-292 sample pause/resume.93170 libivd-did-342 standard carryover; o implementation verification: libivd-15-09p.Lsvn-1008-dp sit backflow control; o effectiveness verification: libivd-15-09f.Lsvn-1008-dr; o probability: 1; o severity: 3; o risk index: 3; o residual risk evaluation: a; o new hazards: none; mitigation(s) sufficient yes; no.Root cause: based on the investigation results the root cause of the carryover between sample tests was due to worn fluidics tubing.Conclusion: based on the investigation results the root cause of the carryover between sample tests was due to worn fluidics tubing.The fse confirmed the issue and replaced the worn sit tubing and 4 way valve manifold.After the repair, the instrument was rebooted, tested, and functioning as expected.No one was harmed or injured, and no medical diagnosis was performed due to any incorrect results.The safety risk is moderate, s3, and there was no impact to patient health or safety.H3 other text : see h10.
|